NGHIÊN CỨU HỘI CHỨNG CHUYỂN HÓA THEO NCEP-ATP III Ở BỆNH NHÂN THẬN NHÂN TẠO CHU KỲ TẠI BỆNH VIỆN BẠCH MAI

Abstract

Metabolic syndrome is one of important elements that raises mortality rate in hemodialysis patients, which it increases the risk of death from second to four times. The objective of the study was to investigate the prevalence and characteristics of metabolic syndrome according to NCEP - ATP III and look for some factors related to metabolic syndrome in hemodialysis patients in Bach Mai hospital. Subjects and methods: Including 160 hemodialysis patients at the Center of Kidney - urology and dialysis, Bach Mai hospital. Research method: cross-sectional description. Results: The prevalence of metabolic syndrome in hemodialysis patients was 54,4%. The prevalence of abdominal obesity was 19,4%, the average value abdominal obesity was 78,51 ± 8,89 ; The prevalence of hypertension was 74,4%, the average value systolic blood pressure and diastolic blood pressure were 138,6 ± 18,2 and 79,1 ± 12,1  mmHg; The prevalence of hyperglycemia was 61,3%, the average value blood glucose was 6,6 ± 2,29 mmol/l; The prevalence of triglyceride increase was 41,3%, the average value triglyceride was 1,95 ± 1,33 mmol/l. The prevalence of HDL-C increase was 66,9%, the average value HDL-C was 1,06 ± 0,38 mmol/l. Conclusion: The prevalence of metabolic syndrome in hemodialysis patients is high, in which hypertension and HDL disturbances are higher than others.